Igarashi A, Katsunuma T, Nagano Y, Komazaki H, et al. Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study. Br J Dermatol 2024 Nov 28:ljae458. doi: 10.1093.
PMID: 39607831